Profile
Richard E.
Armer, formerly a Research Director at Lectus Therapeutics Ltd., Principal at Pfizer Inc., Ardana Plc, and Oxagen Ltd., and Chief Scientific Officer at Redx Pharma Plc (2014-2024).
Former positions of Richard E. Armer
| Companies | Position | End |
|---|---|---|
| REDX PHARMA LTD | Chief Tech/Sci/R&D Officer | 2024-03-31 |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Corporate Officer/Principal | - |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Health Technology |
Redx Pharma Plc
Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
- Stock Market
- Insiders
- Richard E. Armer
















